NCT05975073
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05975073
Title A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DNK | CAN | AUS

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91090 United States Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
Community Health Network MD Anderson Cancer Center - North Indianapolis Indiana 46250 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Health Partners Cancer Center at Regions Hospital Saint Paul Minnesota 55102 United States Details
Astera Cancer Care East Brunswick New Jersey 08816 United States Details
New York University Grossman School of Medicine and New York University Langone Hospitals New York New York 10016 United States Details
Columbia University Irving Medical Center New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Durham North Carolina 27710 United States Details
Prisma Health Upstate Greenville South Carolina 29605 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Next Oncology Irving Texas 75039 United States Details
The Queen Elizabeth Hospital Woodville South South Australia 5011 Australia Details
Monash Medical Centre Clayton Victoria 3168 Australia Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Rigshospitalet Copenhagen 2100 Denmark Details
Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do 13620 South Korea Details
Seoul National University Hospital Seoul 03080 South Korea Details
Severance Hospital Yonsei University Health System Seoul 03722 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Hospital Universitari Vall d Hebron Barcelona Catalonia 08035 Spain Details
Hospital Universitario Ramon y Cajal Madrid 28034 Spain Details
National Cheng Kung University Hospital Tainan 70403 Taiwan Details
National Taiwan University Hospital Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field